Adagrasib (Krasati®) en cáncer colorectal metastásico
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1437453

http://www.fda.gov/medical-devices/medical-device-recalls/teleflex-and-arrow-international-recall-arrow-endurance-extended-dwell-peripheral-catheter-system

FDA Roundup: June 23, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-23-2023

FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs
http://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs

FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-certain-patients-duchenne-muscular-dystrophy

FDA Inspection Blitz Leads to More Than 180 Warning Letters to Retailers for the Illegal Sale of Youth-Appealing Elf Bar and Esco Bars E-Cigarettes
http://www.fda.gov/news-events/press-announcements/fda-inspection-blitz-leads-more-180-warning-letters-retailers-illegal-sale-youth-appealing-elf-bar

FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
http://www.fda.gov/news-events/press-announcements/fda-approves-new-class-medicines-treat-pediatric-type-2-diabetes

FDA Roundup: June 20, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-20-2023

FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers
http://www.fda.gov/news-events/press-announcements/fda-launches-pilot-program-help-reduce-risks-associated-using-laboratory-developed-tests-identify

Valoctocogene roxaparvovec (ROCTAVIANTM) para adultos con hemofilia A severa
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1428153